Related references
Note: Only part of the references are listed.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
Robert Sackstein et al.
LABORATORY INVESTIGATION (2017)
Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma
Jared Klarquist et al.
CANCER RESEARCH (2016)
T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines
Angela Vasaturo et al.
CANCER RESEARCH (2016)
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
Rikke Andersen et al.
CLINICAL CANCER RESEARCH (2016)
Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma
Sarah A. Weiss et al.
HUMAN PATHOLOGY (2016)
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Carsten Denkert et al.
MODERN PATHOLOGY (2016)
Neoantigen landscape dynamics during human melanoma-T cell interactions
Els M. E. Verdegaal et al.
NATURE (2016)
Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy
Maryann E. Mikucki et al.
ONCOIMMUNOLOGY (2016)
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
M. E. Mikucki et al.
NATURE COMMUNICATIONS (2015)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Human Hemato-Lymphoid System Mice: Current Use and Future Potential for Medicine
Anthony Rongvaux et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
D. Bedognetti et al.
BRITISH JOURNAL OF CANCER (2013)
Overcoming Current Limitations in Humanized Mouse Research
Michael A. Brehm et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
Brian J. Cameron et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy
Sivan Sapoznik et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Eva Ellebaek et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The pros and cons of chemokines in tumor immunology
Antonella Viola et al.
TRENDS IN IMMUNOLOGY (2012)
High endothelial venules (HEVs) in human melanoma lesions Major gateways for tumor-infiltrating lymphocytes
Ludovic Martinet et al.
ONCOIMMUNOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2011)
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Homeostatic chemokine receptors and organ-specific metastasis
Albert Zlotnik et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
Weiyi Peng et al.
CLINICAL CANCER RESEARCH (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy
Khoi Q. Tran et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
SA Rosenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
MH Kershaw et al.
HUMAN GENE THERAPY (2002)
Share Paper
